Abstract: The present invention provides a therapeutic and/or prophylactic agent for inflammatory bowel disease and an NF-kB activation inhibitor, each of which comprises chitin nanofibers or chitosan nanofibers.
Type:
Application
Filed:
June 27, 2012
Publication date:
December 11, 2014
Applicants:
National University Corporation Tottori University, Tottori Prefectural Government